DEA Proposes Allowing Federally Certified Opioid Treatment Programs To Operate Mobile Units Without A Separate Registration

The Drug Enforcement Administration (DEA) recently proposed revising its regulations for federally certified opioid treatment programs (OTPs) to allow the programs to operate a mobile component without obtaining a separate registration. Such programs could dispense narcotic drugs in schedules II-V at a remote location for the purpose of maintenance or detoxification treatment. The proposed rule would consider the mobile program to be a “coincident” activity.

Specifically, for OTPs with mobile components, the DEA said it would waive the requirement of a separate registration at each principal place of business or professional practice where controlled substances are dispensed, as long . . .